Search

Displaying results 4261 - 4270 of 10000 in total
  1. Drug

    Butylphthalide

    go.drugbank.com/drugs/DB12749
    Investigational

    Butylphthalide has been used in trials studying the prevention of Restenosis.

    Synonyms: 3-n-butylphthalide, DL-3-n-butylphthalideCategories: Heterocyclic Compounds, 2-Ring, Compounds used in a research, industrial, or household setting
  2. Drug

    CTS-1027

    go.drugbank.com/drugs/DB08490
    Investigational

    CTS-1027 has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C Virus Infection.

    Synonyms: 2H-PYRAN-4-CARBOXAMIDE, 4-(((4-(4-CHLOROPHENOXY)PHENYL)SULFONYL)METHYL)TETRAHYDRO-N-HYDROXY-, 4-(((4-(4-CHLOROPHENOXY)PHENYL)SULFONYL)-METHYL) TETRAHYDRO-N-HYDROXY-2H-PYRAN-4-CARBOXAMIDE
  3. Drug

    Ibutamoren

    go.drugbank.com/drugs/DB18214
    Investigational

    Synonyms: 2-amino-n-(3-(benzyloxy)-1-(1-methanesulfonyl-1,2-dihydrospiro(indole-3,4'-piperidin)-1'-yl)-1-oxopropan-2-yl)-2-methylpropanamide, 2-amino-n-((r)-2-(benzyloxy)-1-((1-(methylsulfonyl)spiro(indoline-3,4'-piperidin)-1'-yl)carbonyl)ethyl)-2-methylpropionamideCategories: Heterocyclic Compounds, 2-Ring
  4. Drug

    3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

    go.drugbank.com/drugs/DB08535
    Experimental

    Synonyms: 3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine
  5. Drug

    N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide

    go.drugbank.com/drugs/DB07499
    Experimental

    Synonyms: N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide
  6. Drug

    [N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine

    go.drugbank.com/drugs/DB03081
    Investigational

  7. Drug

    Indolepropionic acid

    go.drugbank.com/drugs/DB02758
    Investigational

    Synonyms: 3-(3-Indole)propionic acid, 3-(3-Indolyl)propanoic acidCategories: Heterocyclic Compounds, 2-Ring
  8. Drug

    Repotrectinib

    go.drugbank.com/drugs/DB16826
    ApprovedInvestigational

    This approval is based on favorable results from the TRIDENT-1 study, where the objective response rate was 79% in TKI-naive patients and 38% in TKI-pretreated patients respectively.[L48741] … Repotrectinib is a next-generation tyrosine kinase inhibitor (TKI) specifically designed to address resistance in the treatment of non-small cell lung cancer (NSCLC), specifically due to mutations in the

    Categories: MATE 2 Inhibitors, P-glycoprotein inhibitorsSynonyms: (3R,6S,)-45-FLUORO-3,6-DIMETHYL-5-OXA-2,8-DIAZA-1(5,3)-PYRAZOLO(1,5-A)PYRIMIDINA-4(1,2)-BENZENANONAPHAN-9-ONE, (7S,13R)-11-Fluoro-7,13-Dimethyl-6,7,13,14-Tetrahydro-1,15-Ethenopyrazolo[4,3-F][1,4,8,10]Benzoxatriazacyclotridecin-4(5H)-One
  9. Drug

    4-(N,N-Dimethylamino)cinnamoyl-CoA

    go.drugbank.com/drugs/DB04117
    Experimental

    Synonyms: 4-(N,N-Dimethylamino)cinnamoyl-CoA
  10. Drug

    4-epi-vancosaminyl derivative of vancomycin

    go.drugbank.com/drugs/DB04431
    Experimental

    Synonyms: 4-epi-vancosaminyl derivative of vancomycin